- Home
- TKLF vs CRIS Comparison
TKLF vs CRIS Comparison
Compare TKLF & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- CRIS
- Stock Information
- Founded
- TKLF 2006
- CRIS 2000
- Country
- TKLF Japan
- CRIS United States
- Employees
- TKLF N/A
- CRIS N/A
- Industry
- TKLF Other Specialty Stores
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TKLF Consumer Discretionary
- CRIS Health Care
- Exchange
- TKLF Nasdaq
- CRIS Nasdaq
- Market Cap
- TKLF 15.6M
- CRIS 18.6M
- IPO Year
- TKLF 2022
- CRIS 2000
- Fundamental
- Price
- TKLF $3.30
- CRIS $1.49
- Analyst Decision
- TKLF
- CRIS Strong Buy
- Analyst Count
- TKLF 0
- CRIS 2
- Target Price
- TKLF N/A
- CRIS $16.50
- AVG Volume (30 Days)
- TKLF 171.8K
- CRIS 76.1K
- Earning Date
- TKLF 12-17-2025
- CRIS 11-06-2025
- Dividend Yield
- TKLF N/A
- CRIS N/A
- EPS Growth
- TKLF N/A
- CRIS N/A
- EPS
- TKLF 1.57
- CRIS N/A
- Revenue
- TKLF $210,119,238.00
- CRIS $11,405,000.00
- Revenue This Year
- TKLF N/A
- CRIS $2.72
- Revenue Next Year
- TKLF N/A
- CRIS $8.27
- P/E Ratio
- TKLF $2.10
- CRIS N/A
- Revenue Growth
- TKLF 7.38
- CRIS 12.24
- 52 Week Low
- TKLF $2.20
- CRIS $1.02
- 52 Week High
- TKLF $5.10
- CRIS $5.00
- Technical
- Relative Strength Index (RSI)
- TKLF 43.02
- CRIS 40.22
- Support Level
- TKLF $3.04
- CRIS $1.46
- Resistance Level
- TKLF $3.48
- CRIS $1.68
- Average True Range (ATR)
- TKLF 0.26
- CRIS 0.08
- MACD
- TKLF -0.00
- CRIS -0.00
- Stochastic Oscillator
- TKLF 43.77
- CRIS 13.64
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.